These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6849741)

  • 1. Cardiovascular effects of indoramin in man--a dose ranging study.
    Nicholls DP; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1983 Jan; 15(1):31-6. PubMed ID: 6849741
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular effects of intravenous indoramin hydrochloride in man.
    Coleman AJ; Leary WP; Asmal AC
    J Int Med Res; 1979; 7(6):511-8. PubMed ID: 520654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical pharmacology of indoramin.
    Shanks RG
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S8-15. PubMed ID: 2423804
    [No Abstract]   [Full Text] [Related]  

  • 4. On the mechanisms of hypotensive action of indoramin.
    Gulati K; Srimal RC; Dhawan BN
    Pol J Pharmacol Pharm; 1978; 30(6):811-8. PubMed ID: 755245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of intravenous indoramin on the hemodynamic adaptation at rest and during exercise in chronic congestive heart failure.
    De Kock MR; Detry JM
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S107-11. PubMed ID: 2423782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation into the cardioregulatory properties of the alpha 1-adrenoceptor blocker indoramin.
    Pierce V; Shepperson NB; Todd MH; Waterfall JF
    Br J Pharmacol; 1986 Feb; 87(2):433-41. PubMed ID: 3955309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of indoramin, labetalol and alinidine on sympathetic function in normal man.
    Nicholls DP; McNeill J; O'Connor PC; Harron DW; Leahey WJ; Shanks RG
    Br J Clin Pharmacol; 1984 Aug; 18(2):215-21. PubMed ID: 6386022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cardiovascular effects of centrally and peripherally administered indoramin in conscious rats.
    Porter JP; Bonham AC; Mangiapane ML; Webb RL; Brody MJ
    Eur J Pharmacol; 1985 Feb; 109(1):9-17. PubMed ID: 3996469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of indoramin and propranolol on cardiovascular response to cold in hypertensive patients.
    Velasco M; Urbina-Quintana A; Andrews-Figueroa P; Nieves D; Hernández E; Guevara-Casado J; Hernández-Pieretti O
    Clin Pharmacol Ther; 1982 Jul; 32(1):7-11. PubMed ID: 7083732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of indoramin on finger blood flow in vasospastic patients.
    Clement DL
    Eur J Clin Pharmacol; 1978 Dec; 14(5):331-3. PubMed ID: 729626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential blockade of alpha-adrenoceptors by indoramin.
    Nicholls DP; O'Connor PC; Harron DW; Leahey WJ; Shanks RG
    Br J Clin Pharmacol; 1984 Jun; 17(6):719-28. PubMed ID: 6146328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute and chronic effects of indoramin on renal function, hemodynamics, and transport.
    Morrison G; Spar B; Walker BR; Goldfarb S
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S25-9. PubMed ID: 2423792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation into mechanism of lack of reflex tachycardia in response to hypotensive action of indoramin in dogs.
    Harron DW; Kerr MJ; Shanks RG
    J Cardiovasc Pharmacol; 1984; 6(4):596-600. PubMed ID: 6206312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings: Alpha-adrenoceptor inhibition from indoramin in man.
    Boakes AJ; Prichard BN; Teoh PC
    Br J Pharmacol; 1972 Feb; 44(2):378P-379P. PubMed ID: 4148923
    [No Abstract]   [Full Text] [Related]  

  • 15. Indoramin as an antihypertensive agent in the treatment of essential hypertension. A multicentre trial.
    Bednarek MR; Schoeman HS
    S Afr Med J; 1983 Mar; 63(11):398-400. PubMed ID: 6338603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central and peripheral contribution to the antihypertensive action of indoramin.
    Baum T; Shropshire AT
    Eur J Pharmacol; 1975 May; 32(1):30-8. PubMed ID: 168091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the renal effects of indoramin and prazosin.
    Strandhoy JW
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S151-5. PubMed ID: 2423789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indoramin, a drug with prevalent antihypertensive activity: experimental study].
    Marmo E; Rossi F; Caputi AP; Lampa E; Petrarca R; Ottavo R
    Clin Ter; 1979 Feb; 88(3):233-62. PubMed ID: 445975
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence for a central sympathoinhibitory action of prazosin and indoramin.
    Ramage AG
    Eur J Pharmacol; 1986 Feb; 121(1):83-9. PubMed ID: 3956575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases.
    Holmes B; Sorkin EM
    Drugs; 1986 Jun; 31(6):467-99. PubMed ID: 3525084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.